World Journal of Urology

, Volume 37, Issue 12, pp 2715–2719 | Cite as

The risk factors of urinary tract infection after transurethral resection of bladder tumors

  • Yuki KohadaEmail author
  • Akihiro Goriki
  • Kazuma Yukihiro
  • Shinya Ohara
  • Mitsuru Kajiwara
Original Article



Few studies mention the necessity of antimicrobial prophylaxis (AMP) for transurethral resection of bladder tumor (TURBT) and the risk factors for postoperative urinary tract infections (UTIs) after TURBT. To evaluate the necessity of AMP and to detect the risk of UTIs, we examined the perioperative clinical factors.


687 patients who underwent TURBT between 2006 and 2017 at Hiroshima Prefectural Hospital were examined retrospectively. We defined the postoperative UTIs as febrile UTIs (≥ 38 °C). The AMP for the TURBT that we used was mostly cephalosporin generation 1. The association between the perioperative clinical/pathological factors and postoperative UTIs was assessed by logistic regression retrospectively.


21 patients (3.1%) suffered from postoperative UTIs, and almost all of them were successfully treated with the immediate administration of antibiotics. Univariate analysis showed that past pelvic radiotherapy (p = 0.024, odds ratio (OR) 6.00), tumor size (≥ 2cm) (p = 0.008, OR 3.38), age (≥ 75 years) (p = 0.036, OR 2.65), preoperative hospital stay (≥ 5 days) (p = 0.017, OR 3.76), asymptomatic pyuria (p = 0.038, OR 2.54) and bacteriuria (p = 0.044, OR 2.97) were all associated with postoperative UTIs.


We demonstrated that AMP was effective for patients who underwent TURBT, and history of pelvic radiotherapy, high age, preoperative hospital stay and a certain tumor size were the risk factors as well as pyuria and bacteriuria of postoperative UTIs.


Transurethral resection of bladder tumors Urinary tract infections Antimicrobial prophylaxis Surgical site infection 



Transurethral resection of bladder tumors


Antimicrobial prophylaxis


Urinary tract infections


Author contributions

YK: protocol/project development, data management, data analysis, and manuscript writing. AG: manuscript editing. KY: data collection. SO: manuscript editing. MK: protocol/project development.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study formal consent is not required. This article does not contain any studies with animals performed by any of the authors.


  1. 1.
    Goldwasser B, Bogokowsky B, Nativ O et al (1983) Urinary infections following transurethral resection of bladder tumors: rate and source. J Urol 129:1123–1124CrossRefGoogle Scholar
  2. 2.
    Appell RA, Flynn JT, Paris AM, Blandy JP (1980) Occult bacterial colonization of bladder tumors. J Urol 124:345–346CrossRefGoogle Scholar
  3. 3.
    Kanamaru S, Terai A, Ishitoya S et al (2004) Assessment of a protocol for prophylactic antibiotics to prevent perioperative infection in urological surgery: a preliminary study. Int J Urol 11:355–363CrossRefGoogle Scholar
  4. 4.
    MacDermott JP, Ewing RE, Somerville JF, Gray BK (1988) Cephradine prophylaxis in transurethral procedures for carcinoma of the bladder. Br J Urol 62:136–139CrossRefGoogle Scholar
  5. 5.
    Gasser TC, Wisard M, Frei R (1996) Oral fleroxacin prophylaxis in transurethral surgery. J Urol 156:146–148CrossRefGoogle Scholar
  6. 6.
    di Silverio ZF, Ferrone G, Carati I (1990) Prophylactic chemotherapy with fosfomycin trometamol during transurethral surgery and urological manoeuvres: results of a multicentre study. Infection 18:98–102CrossRefGoogle Scholar
  7. 7.
    Amin M (1992) Antibacterial prophylaxis in urology: a review. Am J Med 92:114–117CrossRefGoogle Scholar
  8. 8.
    Alsaywid BS, Smith GH (2013) Antibiotic prophylaxis for transurethral urological surgeries: systematic review. Urol Ann 5:61–74CrossRefGoogle Scholar
  9. 9.
    Janknegt RA (1992) Prophylaxis in urological surgery. Infection 20:217–224CrossRefGoogle Scholar
  10. 10.
    Upton JD, Das S (1986) Prophylactic antibiotics in transurethral resection of bladder tumors: are they necessary? Urology 27:421–423CrossRefGoogle Scholar
  11. 11.
    Delavierre D, Huiban B, Fournier G et al (1993) The value of antibiotic prophylaxis in transurethral resection of bladder tumors: apropos of 61 cases. Prog Urol 3:577–582PubMedGoogle Scholar
  12. 12.
    Badenoch DF, Murdoch DA, Tiptaft RC (1990) Microbiological study of bladder tumors, their histology and infective complications. Urology 35:5–8CrossRefGoogle Scholar
  13. 13.
    Yokoyama M, Fujii Y, Yoshida S et al (2009) Discarding antimicrobial prophylaxis for transurethral resection of bladder tumor: a feasibility study. Int J Urol 16:61–63CrossRefGoogle Scholar
  14. 14.
    Wolf JS Jr, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ (2008) Urologic surgery antimicrobial prophylaxis best practice policy panel: best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379–1390CrossRefGoogle Scholar
  15. 15.
    Yamamoto S, Shigemura K, Kiyota H et al (2016) Essential Japanese guidelines for the prevention of perioperative infections in the urological field: 2015 edition. Int J Urol 23:814–824CrossRefGoogle Scholar
  16. 16.
    Grabe M, Bjerklund-Johansen TE, Botto H et al (2013) Guidelines on urological infections. Accessed 25 Mar 2019
  17. 17.
    Wagenlehner FM, Wagenlehner C, Schinzel S, Naber KG (2005) Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Eur Urol 47:549–556CrossRefGoogle Scholar
  18. 18.
    Qiang W, Jianchen W, MacDonald R, Monga M, Wilt TJ (2005) Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review. J Urol 173:1175–1181CrossRefGoogle Scholar
  19. 19.
    Prasad KN, Pradhan S, Datta NR (1995) Urinary tract infection in patients of gynecological malignancies undergoing external pelvic radiotherapy. Gynecol Oncol 57:380–382CrossRefGoogle Scholar
  20. 20.
    Roberts FJ, Murphy J, Ludgate C (1990) The value and significance of routine urine cultures in patients referred for radiation therapy of prostatic malignancy. Clin Oncol 2:18–21CrossRefGoogle Scholar
  21. 21.
    Bialas I, Bessell EM, Sokal M, Slack R (1989) A prospective study of urinary tract infection during pelvic radiotherapy. Radiother Oncol 16:305–309CrossRefGoogle Scholar
  22. 22.
    Bessell EM, Granville-White M (1994) The effect of prophylactic trimethoprim on aerobic urinary tract infection during pelvic radiotherapy and the incidence of infections due to fastidious or anaerobic organisms. Clin Oncol 6:116–120CrossRefGoogle Scholar
  23. 23.
    Çetinel B (2015) Chemotherapy and pelvic radiotherapy-induced bladder injury. Urologia 82:2–5CrossRefGoogle Scholar
  24. 24.
    Matulewicz RS, Sharma V, McGuire BB et al (2015) The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: an analysis of ACS NSQIP data. Urol Oncol 33:19–24CrossRefGoogle Scholar
  25. 25.
    Tsujinaka T, Yamamoto K, Fujita J et al (2013) Subcuticular sutures versus staples for skin closure after open gastrointestinal surgery: a phase 3, multicentre, open-label, randomised controlled trial. Lancet 382:1105–1112CrossRefGoogle Scholar
  26. 26.
    Pereira HO, Rezende EM, Couto BR (2015) Length of preoperative hospital stay: a risk factor for reducing surgical infection in femoral fracture cases. Rev Bras Ortop 50:638–646CrossRefGoogle Scholar
  27. 27.
    Hamasuna R, Betsunoh H, Sueyoshi T et al (2004) Bacteria of preoperative urinary tract infections contaminate the surgical fields and develop surgical site infections in urological operations. Int J Urol 11:941–947CrossRefGoogle Scholar
  28. 28.
    Yamamoto H, Omote K, Sonoda H, Namiki A (2002) A case of sepsis that developed during transurethral resection of the prostate. J Anesth 16:242–244CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of UrologyHiroshima Prefectural HospitalHiroshimaJapan

Personalised recommendations